US Markets

Moderna concludes advanced talks with EU for COVID-19 vaccine supply

Credit: REUTERS/BRIAN SNYDER

Moderna Inc said on Monday it has concluded advanced exploratory talks with the European Commission to supply 80 million doses of its COVID-19 vaccine candidate.

Aug 24 (Reuters) - Moderna Inc MRNA.O said on Monday it has concluded advanced exploratory talks with the European Commission to supply 80 million doses of its COVID-19 vaccine candidate.

The potential agreement provides for an option for member states to buy an additional 80 million doses for a total of up to 160 million doses, the company said.

(Reporting by Ankur Banerjee in Bengaluru; Editing by Arun Koyyur)

((ankur.banerjee@thomsonreuters.com;; within U.S. +1 646 223 8780, outside U.S. +91 80 6749 6132; Twitter: @AnkurBanerjee17;))

The views and opinions expressed herein are the views and opinions of the author and do not necessarily reflect those of Nasdaq, Inc.

In This Story

MRNA

Latest Markets Videos

Reuters

Reuters, the news and media division of Thomson Reuters, is the world’s largest international multimedia news provider reaching more than one billion people every day. Reuters provides trusted business, financial, national, and international news to professionals via Thomson Reuters desktops, the world's media organizations, and directly to consumers at Reuters.com and via Reuters TV.

Learn More